3,5-dibromo-1-{[4-(trifluoromethyl)phenyl]methyl}-1H-1,2,4-triazole, 95.0%, 2g

2,2-Difluorohexanoic acid, 95.0%, 250mg

Chlorhydrate de cystéamine, min 99 %, pour la biochimie, 25 g, emballage en verre

2-[(pyridin-4-yl)amino]acetic acid, 98+%, 500mg

tert-Butyl (4R)-4-[(E)-3-bromoprop-1-enyl]-2,2-dimethyl-oxazolidine-3-carboxylate, 97% mix TBC as stabilizer, 250mg

(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoic acid, 95+%, 500mg

4-phenyl-1,3-dihydro-2H-imidazol-2-one, 95.0%, 250mg

(1-oxopyrrolo[1,2-d][1,2,4]triazin-2(1H)-yl)acetonitrile, 95.0%, 1g

N-(Hydroxymethyl)acetamide, 95.0%, 5g

4-(4-Chlorophenyl)thiomorpholine 1,1-Dioxide>98.0%(GC)(T)5g

(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol, 95.0%, 25mg

7-Bromo-2-oxo-2H-chromene-3-carboxylic acid, 97%, 1g

3-Iodo-1-(tetrahydro-pyran-2-yl)-1H-pyrazole-4-carbaldehyde, 95.0%, 5g